Literature DB >> 16440600

Temporal changes in renal endoglin and TGF-beta1 expression following ureteral obstruction in rats.

M Prieto1, A B Rodríguez-Peña, A Düwel, J V Rivas, N Docherty, F Pérez-Barriocanal, M Arévalo, C P H Vary, C Bernabeu, J M López-Novoa, N Eleno.   

Abstract

Chronic renal disease is characterized by the accumulation of extracellular matrix proteins in the kidney and a loss of renal function. Tubulointerstitial fibrosis has been reported to play an important role in the progression of chronic renal diseases. Transforming growth factor-beta1 (TGF-beta1) is a profibrotic cytokine playing a major contribution to fibrotic kidney disease. Endoglin is a membrane glycoprotein of the TGF-beta1 receptor system. The aim of this work was to determine the time-course expression of renal type I and IV collagens, endoglin and TGF-beta1 in a rat model of induced tubulointerstitial fibrosis at 1, 3, 10 and 17 days after unilateral ureteral obstruction (UUO). In 17 days-ligated (L)-renal samples, a marked interstitial fibrosis was detected by Masson's trichromic and Sirius red staining, accompanied by an increase in type I collagen expression as shown by immunohistochemical analysis. Northern blot studies revealed a progressive increase in collagen alpha2(I), TGF-beta1 and endoglin mRNA expression in L kidneys when compared with the corresponding non-ligated (NL) kidneys from the animals subjected to left UUO. Seventeen days after UUO, significant increases in collagen alpha2(I), collagen alpha1(IV), TGF-beta1 and endoglin mRNA levels were detected in L kidneys vs NL kidneys. Significantly higher levels of the protein endoglin were found in L kidneys than in NL kidneys 10 and 17 days following obstruction. A marked increase expression for endoglin and TGF-beta1 was localized in renal interstitium by immunohistochemical studies 17 days after obstruction. In conclusion, this work reports the upregulation of endoglin coincident to that of its ligand TGF-beta1 in the kidneys of rats with progressive tubulointerstitial fibrosis induced by UUO.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16440600     DOI: 10.1007/BF03168452

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  33 in total

Review 1.  Pathophysiology of reno-ureteral colic.

Authors:  F Travaglini; R Bartoletti; M Gacci; M Rizzo
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

2.  Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction.

Authors:  A Rodríguez-Peña; M Prieto; A Duwel; J V Rivas; N Eleno; F Pérez-Barriocanal; M Arévalo; J D Smith; C P Vary; C Bernabeu; J M López-Novoa
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

Review 3.  Obstructive nephropathy and renal fibrosis.

Authors:  Saulo Klahr; Jeremiah Morrissey
Journal:  Am J Physiol Renal Physiol       Date:  2002-11

4.  Endoglin is expressed in the chicken vasculature and is involved in angiogenesis.

Authors:  U Raab; P Lastres; M A Arévalo; J M López-Novoa; C Cabañas; E J de la Rosa; C Bernabéu
Journal:  FEBS Lett       Date:  1999-10-08       Impact factor: 4.124

5.  Regulated expression on human macrophages of endoglin, an Arg-Gly-Asp-containing surface antigen.

Authors:  P Lastres; T Bellon; C Cabañas; F Sanchez-Madrid; A Acevedo; A Gougos; M Letarte; C Bernabeu
Journal:  Eur J Immunol       Date:  1992-02       Impact factor: 5.532

6.  Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.

Authors:  N P Barbara; J L Wrana; M Letarte
Journal:  J Biol Chem       Date:  1999-01-08       Impact factor: 5.157

7.  Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Authors:  W A Border; N A Noble; T Yamamoto; J R Harper; Y u Yamaguchi; M D Pierschbacher; E Ruoslahti
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

8.  Transforming growth factor-beta receptor types I and II are expressed in renal tubules and are increased after chronic unilateral ureteral obstruction.

Authors:  P M Sutaria; M Ohebshalom; T A McCaffrey; E D Vaughan; D Felsen
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

9.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.

Authors:  Y Isaka; D K Brees; K Ikegaya; Y Kaneda; E Imai; N A Noble; W A Border
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

10.  Expression of endoglin mRNA and protein in human vascular smooth muscle cells.

Authors:  P J Adam; G J Clesham; P L Weissberg
Journal:  Biochem Biophys Res Commun       Date:  1998-06-09       Impact factor: 3.575

View more
  6 in total

Review 1.  Role of endoglin in fibrosis and scleroderma.

Authors:  Janita A Maring; Maria Trojanowska; Peter ten Dijke
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

2.  Endoglin in liver fibrosis.

Authors:  Kenneth W Finnson; Anie Philip
Journal:  J Cell Commun Signal       Date:  2011-12-01       Impact factor: 5.782

3.  Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes.

Authors:  Patricia Alvarez-Muñoz; Michael Mauer; Youngki Kim; Stephen S Rich; Michael E Miller; Gregory B Russell; José M Lopez-Novoa; M Luiza Caramori
Journal:  J Diabetes Complications       Date:  2009-04-23       Impact factor: 2.852

4.  Circulating endoglin concentration is not elevated in chronic kidney disease.

Authors:  David M Charytan; Alexander M Helfand; Brian A MacDonald; Angeles Cinelli; Raghu Kalluri; Elisabeth M Zeisberg
Journal:  PLoS One       Date:  2011-08-19       Impact factor: 3.240

5.  L-Endoglin overexpression increases renal fibrosis after unilateral ureteral obstruction.

Authors:  Bárbara Oujo; José M Muñoz-Félix; Miguel Arévalo; Elena Núñez-Gómez; Lucía Pérez-Roque; Miguel Pericacho; María González-Núñez; Carmen Langa; Carlos Martínez-Salgado; Fernando Perez-Barriocanal; Carmelo Bernabeu; José M Lopez-Novoa
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

6.  Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy.

Authors:  Tessa Gerrits; Malu Zandbergen; Ron Wolterbeek; Jan A Bruijn; Hans J Baelde; Marion Scharpfenecker
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.